Fieldview Capital Management »

Royalty Pharma shares owned by Fieldview Capital Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Fieldview Capital Management from 13F filings

Historical chart of Fieldview Capital Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Fieldview Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Fieldview Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0M 41k 47.97

More positions owned by Fieldview Capital Management

First Ctzns Bancshares Inc D Cl A (FCNCA)
WesBan (WSBC)
Biogen Idec (BIIB)
Teradyne (TER)
Popular Com New (BPOP)
Broadstone Net Lease (BNL)
TowneBank (TOWN)
National Health Investors (NHI)
Darling International (DAR)
AutoZone (AZO)
Five Below (FIVE)
Atmus Filtration Technologies Ord (ATMU)
Hasbro (HAS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Sun Communities (SUI)

View all positions for Fieldview Capital Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
FMR
BlackRock
Baillie Gifford & Co
Adage Capital Partners GP
Swedbank AB
State Street Corporation
Vanguard Group
Capital World Investors
Geode Capital Management
Caledonia
Victory Capital Management
Vanguard Capital Management
Northern Trust

View all funds holding Royalty Pharma